NCT04389216View on ClinicalTrials.gov

Radiofrequency Ablation (RFA) in Breast Tumors

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

September 9, 2025

Study Completion Date

September 9, 2025

Conditions
Breast Cancer Female
Interventions
DEVICE

Cool-tip electrode for Radiofrequency Ablation

Radiofrequency ablation of the tumour in the surgery group, associated whith axillary surgery when applicable

Trial Locations (2)

08003

Hospital del Mar, Barcelona

08907

Hospital de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Hospital Universitari de Bellvitge

OTHER

NCT04389216 - Radiofrequency Ablation (RFA) in Breast Tumors | Biotech Hunter | Biotech Hunter